Myocardial scarring in minimally symptomatic patients with hypertrophic cardiomyopathy.

被引:0
|
作者
Choudhury, L [1 ]
Mahrholdt, H [1 ]
Wagner, A [1 ]
Eliott, MD [1 ]
Choi, KM [1 ]
Vargas, JM [1 ]
Bonow, RO [1 ]
Judd, RM [1 ]
Kim, RJ [1 ]
机构
[1] Northwestern Univ, Sch Med, Chicago, IL USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3563
引用
收藏
页码:757 / 757
页数:1
相关论文
共 50 条
  • [31] Hypertrophic cardiomyopathy. Proposal for a new classification
    Llamas-Esperon, Guillermo A.
    Llamas-Delgado, Guillermo
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2022, 92 (03): : 377 - 389
  • [32] Sudden death: hypertrophic cardiomyopathy with myocardial scarring and extremely rare coronary origin
    Zuccarino, Flavio
    Moral, Sergio
    Pujol, Elisabet
    EUROPEAN HEART JOURNAL, 2009, 30 (11) : 1355 - 1355
  • [33] Colocalization of Regional MEF2 Activity With Myocardial Scarring In Hypertrophic Cardiomyopathy
    Konno, Tetsuo
    Chen, Dan
    Wang, Libin
    Wakimoto, Hiroko
    Teekakirikul, Polakit
    Seidman, Christine
    Seidman, Jonathan
    CIRCULATION, 2008, 118 (18) : S947 - S947
  • [34] Relation of myocardial scarring to clinical risk factors for sudden death in hypertrophic cardiomyopathy
    Mahrholdt, H
    Wagner, A
    Kupfahl, C
    Choudhury, L
    Bonow, RO
    Sechtem, U
    Judd, RM
    Kim, RJ
    EUROPEAN HEART JOURNAL, 2003, 24 : 137 - 137
  • [35] Widespread Scarring in Apical Hypertrophic Cardiomyopathy
    Islamoglu, Yahya
    Tekbas, Ebru
    Cil, Habib
    Aktas, M. Kemal
    Tekbas, Guven
    Elbey, M. Ali
    EUROPEAN JOURNAL OF GENERAL MEDICINE, 2013, 10 : 103 - 103
  • [36] Ablation of the septum by coil embolization of the septal peforator is a new potential treatment option for patients with symptomatic hypertrophic obstructive cardiomyopathy.
    Denktas, Ali E.
    Loghin, Catalin
    Murtagh, Blaithnead
    LeDoux, John F.
    Giesler, Gregory
    Gomez, Jaime
    Smalling, Richard W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 231M - 232M
  • [37] EFFECTS OF NIFEDIPINE ON LEFT-VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH ASYMPTOMATIC OR MINIMALLY SYMPTOMATIC HYPERTROPHIC CARDIOMYOPATHY
    YAMAKADO, T
    OKANO, H
    HIGASHIYAMA, S
    HAMADA, M
    NAKANO, T
    TAKEZAWA, H
    CIRCULATION, 1990, 81 (02) : 593 - 601
  • [38] Sequencing of the beta myosin heavy chain gene in the patients with hypertrophic cardiomyopathy.
    Goloubenko, MV
    Puzyrev, VP
    Saviouk, VY
    Puzyrev, KV
    Salioukov, VB
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 378 - 378
  • [39] Surgical outcomes and strategy of hypertrophic obstructive cardiomyopathy.
    Zhu Y.B.
    Rajan S.
    Kurian V.M.
    Liu Z.Y.
    Journal of Zhejiang University SCIENCE B, 2006, 7 (2): : 148 - 153
  • [40] REGIONAL MYOCARDIAL BLOOD-FLOW AND METABOLISM AT REST IN MILDLY SYMPTOMATIC PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
    GROVERMCKAY, M
    SCHWAIGER, M
    KRIVOKAPICH, J
    PERLOFF, JK
    PHELPS, ME
    SCHELBERT, HR
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 13 (02) : 317 - 324